Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1)

The summary for the Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1): The purpose of this limited Funding Opportunity Announcement (FOA) is to support the infrastructure to design and conduct multi-institutional Phase I and early Phase II clinical immunotherapy trials for cancer patients, using novel immunomodulatory agents. To realize these goals, the FOA will continue to support the research activities of the Cancer Immunotherapy Trials Network (CITN).
Federal Grant Title: Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-16-501
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.395
CFDA Descriptions: Information not provided
Current Application Deadline: January 24th, 2017
Original Application Deadline: January 24th, 2017
Posted Date: November 25th, 2016
Creation Date: November 25th, 2016
Archive Date: February 24th, 2017
Total Program Funding:
Maximum Federal Grant Award: $1,500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: November 25th, 2016
Applicants Eligible for this Grant
Public and State controlled institutions of higher education - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Only the current awardee of CITN COSC is eligible to apply. See FOA for eligibility details
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-16-501.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)
Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)
NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed)
NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed...
Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required)
Breast and Prostate Cancer Data Quality and Patterns of Care Study
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies in Adults
National Cooperative Drug Discovery Groups for Cancer
More Grants from the National Institutes of Health
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2021 FederalGrants.com